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Abstract 
Solid titration was used to explore the solubility isotherms of partially- (Srx-HAp, x = 1, 5, 10, 40, 
60 mole%) and fully-substituted strontium hydroxyapatite (Sr-HAp). Solubility increased with 
increase of strontium content. No other phase than Sr-substituted HAp, corresponding to the 
original titrant was detected in the solid present at equilibrium; in particular DCPD was not detected 
at low pH. The increase of solubility with Sr content is interpreted as a destabilization of the crystal 
structure by the larger strontium ion. Carbonated HAp was formed in simulated body fluid (SBF) 
containing carbonate on seeding with Sr10-HAp, but the precipitate was strontium-substituted on 
seeding with Sr-HAp. Strontium-substituted HAp might be usable as a template for the growth of 
new bone, since nucleation appears to be facilitated. 
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1. Introduction 
Hydroxyapatite (HAp), Ca5(PO4)3OH, is the principal parent mineral of bone and tooth tissue.  
However, it is never found in a pure form in nature since substitution occurs readily by other 
elements such as sodium, magnesium, carbonate and fluoride; such substitutions can occur at all 
three site types: calcium, phosphate and hydroxide. In particular, strontium may substitute at Ca 
sites, forming a continuous solid solution (Srx-HAp) up to full substitution (Sr-HAp) due to 
chemical similarity.  Strontium is believed to play an important role in the treatment of 
osteoporosis and enhancement of bone remineralization as it is associated with a reduction of bone 
resorption, an increase in the formation of new bone, and a decrease in the risk of bone fracture [1]. 
Consequently, a number of strontium-containing materials have been extensively used as a bone 
filler, such as partially strontium-substituted HAp [2-5], α-TCP [6], and CaSiO3 [7], as well as 
strontium-containing cement [8, 9]. In addition, strontium-containing toothpaste was developed to 
enhance the remineralization of dental enamel [10], and recently drugs such as strontium ranelate 
(SrR) [11] have been suggested for use as a daily supplement to increase bone mineral density.  
 
However, the mechanism and behaviour of strontium in such systems are controversial. Grynpas 
[12] thought that the incorporation of strontium induced hypomineralization by weakening the 
apatite lattice and so increasing bone mineral solubility, while it was recently reported that no 
stimulation of new bone formation was found in ovariectomized rats after SrR intake for three 
months [13]. On the other hand, Christoffersen et al. [14] and Dedhiya et al. [15] found that 
strontium significantly inhibited the dissolution of HAp, and a “surface complex”, Ca3Sr2(PO4)3OH 
(40% Sr-substituted HAp, Sr40-HAp) has been postulated to account for such dissolution 
retardation [16]. But as indicated by Christoffersen et al. [14] themselves, the solubility of 
strontium-substituted apatite increases with the increase of strontium content. The question 
therefore arises of how a more soluble phase could cover a more stable phase spontaneously at 
equilibrium? A thorough check of the effect of strontium on its solubility is necessary. 
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One immediate concern is that the incongruent dissolution of HAp [17-19] has been known since at 
least the 1930s: the apparent solubility increases with increase of the amount of solid present. The 
conclusion of Levinskas and Neuman [20] that no solubility product (SP) for HAp can be calculated 
can be attributed to this. In fact, although a number of dissolution models have been discussed 
before [19], consideration of the method itself is usually neglected. For calcium phosphates, 
difficulties arise from the formation of intermediate phases such as dicalcium hydrogen phosphate 
(DCPD), octacalcium phosphate (OCP) and amorphous calcium phosphate (ACP), which have been 
reported to nucleate more easily, which lead to shifts in solution equlibria. Crucially, however, 
seldom has the attempt been made to analyse the composition and phase constitution of the solid at 
equilibrium as it has been assumed that no phase transformation occurs (HAp is reported as the 
most stable phase at pH > 4.2 [21]), despite the solution Ca/P ratio varying greatly.  Problems are 
commonly ascribed to the formation of complexes [19, 22, 23].  Any such determined solubility 
does not correspond to the original solid, and lacks both precision and accuracy. Furthermore, the 
calculation of a solubility product (SP) requires knowledge of all relevant equilibria, but the 
presence of a dozen or so equilibria has been neglected or ignored, such as for CaH2PO4+, CaPO4- 
[24]. Such simplification is an unwarranted and crude approximation; such calculated SPs are 
therefore meaningless.  
 
Recognizing these difficulties, the solid titration approach for determining mass solubility was 
developed [25, 26]. In this, a series of only very small increments of the relevant solid are added to 
the test solution as the end-point is approached, with the end-point of remnant solid (or new 
precipitate) being detected by a low-angle laser-scattering system; the system depends on the 
complete dissolution of each increment before the next is added. Thus, although the dissolution of 
the solid itself may still be incongruent whilst there is solid present, at the end-point the excess solid 
is vanishingly small, thus avoiding both the appreciable supersaturation and uncertain solution 
composition which arise from a large excess of solid. Using this technique, HAp has been 
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confirmed to be substantially less soluble than previously reported [26]. In particular, DCPD has 
been found not to be the most stable phase at low pH as hitherto believed, rather, it is a 
calcium-deficient HAp which is. Meanwhile, the reliability and reproducibility of solid-titration has 
been confirmed for a relatively simple system, CaF2 [27], with the experimental solubility isotherm 
consistent with the theoretical result over a wide pH range and other reports [28, 29]. Therefore, 
solid titration may be the only viable approach to explore true solution equilibria for complicated 
systems such as the calcium phosphates. The extension to other systems is natural, and in particular 
the effect of strontium is of special interest here, where the debate might arise from failure to 
understand the true solution equilibria.   
 
However, the literature contains little in the way of solubility data of for Srx-HAp [30].  Thus, in 
the present context determination of the true solubility of Sr-containing apatites is both necessary 
and urgent. The aim of the present work was therefore to determine the solid titration curves for 
Srx-HAp, with the composition of the precipitate at equilibrium needing to be determined in order 
to ascertain whether such curves represent solubility isotherms for the titrant solid composition. In 
addition, seeding of these solids in simulated body fluid (SBF) solution might be helpful to 
understand the effect of strontium in vivo.  
 
2. Materials and Methods 
2.1 Titrant preparation 
Strontium-substituted apatite, Srx-HAp [x = Sr/(Ca+Sr) = 1, 5, 10, 40 60 mole%] and 
fully-substituted strontium apatite (Sr-HAp) were synthesized using an hydrothermal method at 
150 °C for 14 h by adding (NH4)2HPO4 solution (analytical grade, Merck, Darmstadt, Germany) 
into a solution of Sr(NO3)2 and Ca(NO3)2 in the corresponding molar ratio (both analytical grade, 
BDH, Poole, England), with the product (Ca+Sr)/P ratio 1.67 (stoichiometric for apatites) as 
previously described [31]. Ammonium hydroxide solution (Aristar, BDH) was used to adjust to 
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initial pH 10. The precipitate was washed several times each with deionized water and absolute 
ethanol, and finally dried at 90 oC overnight.  
 
2.2 Solid titration 
The solubility of each solid Srx-HAp in 600 mL of 100 mM KCl solution at 37.0 ± 0.1 oC was 
investigated. The solution was flushed with nitrogen, and all conditions were as previously reported 
for HAp [26]. The end-point of the titration was determined by a semiconductor-diode 
laser-scattering system (1 mW CW, 194-010, RS Components, UK). The intensity of the initial 
signal was approximately proportional to the amount of added solid. Each addition of the solid, 
even if less than 0.5 mg, caused an obvious step-increase in the laser-detector output signal. With 
time, this signal decreased due to the dissolution of the solid. The time taken depended on the 
particle dissolution rate. When a stable signal was obtained for an hour or more at or very close to 
the original baseline value, it was taken as indicating that the solid added had completely dissolved; 
the next solid addition could then be made. Therefore, the end-point of the titration could be 
unambiguously detected by the output signal remaining higher than the original baseline, indicating 
that no more solid could dissolve or that a new solid had precipitated, or both. The estimate of the 
end-point of the titration was refined by interpolation as previously described [26], after a further 
small increment. The pH value could then be adjusted to a lower value by adding HCl (1 M solution, 
analytical grade, BDH; dropwise) until all solid had dissolved, permitting a further determination.  
 
2.3 Solid formation  
In some cases, “preparative” solid was obtained by further addition of a milligram or so of the 
titrant after the end-point had been reached, allowing a further 10 days for reprecipitation and 
equilibration, including grain growth, so that sufficient material (~1 mg) was available for analysis 
after centrifugation and rinsing with a drop or two or deionized water.  This approach was 
necessary because the amount of solid present at the end-point was intended to be vanishingly small 
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and thus insufficient on its own for characterization. 
 
2.4 Seeding of titrants in SBF 
Sr10-HAp has been widely studied in vitro and used in vivo, in particular as the main inorganic 
phase for the preparation of bone cement [32]. Pure, fully-substituted Sr-HAp is also of special 
interest as the limiting case. These two solids were therefore chosen to study the seeding behaviour 
in simulated body fluid (SBF), prepared according to Kokubo et al. [33], which solution is 
metastable, being greatly supersaturated with respect to HAp. In each case, a 1 mg portion of the 
solid was added into 600 mL SBF solution at 37.0 ± 0.1 oC, and allowed to equilibrate for 2 d (as 
determined by the laser-scattering signal). A second portion of 2-3 mg titrant was then added, and 
allowed to equilibrate for a further 10 d, following which the solid was retrieved by centrifugation, 
and rinsed with one drop of deionized water.  
 
2.5 Characterization 
The constitution of the original titrants was characterized by X-ray diffraction (XRD) (Model 
D/max 2550V, Rigaku, Tokyo, Japan) using Cu Kα (λ = 1.5406 Å) radiation in step-scan mode (2θ 
= 0.02o per step). The precipitate was characterized by selected-area electron diffraction (SAED) 
(Technai G2 20 TEM, FEI, Hillsboro, OR, USA) due to the small amount of ‘preparative’ solid 
obtained at equilibrium. Ring radii were calculated in image-analysis software (QWin, Leica 
Microsystems Imaging Solutions, Cambridge, UK). The composition of titrants and precipitates 
was determined using EDX (LEO 1530 FESEM, Oxford Instruments, Oxford, UK). Five 
determinations were made on different areas, and the mean and standard deviation for each element 
calculated. As carbonate is present in SBF, Fourier Transform Infrared spectroscopy (FT-IR, 
PerkinElmer, USA) was used on the precipitates from those titrations. The morphology of titrants 
and precipitates was observed by field-emission scanning TEM. 
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3. Results   
3.1 Titrant 
The required strontium-substituted apatites were successfully prepared and confirmed to be fully 
apatitic (Fig. 1); although XRD peaks deviated in line with strontium content compared with HAp 
(JCPDs, 72-1243), no other phase was detected. The calculated Sr/(Ca+Sr) ratios were close to the 
theoretical values (Table 1), and the (Ca+Sr)/P ratio close to the stoichiometric value, 1.67. Crystals 
became longer with the increase of strontium content, and in particular for Sr40-HAp and above 
(Fig. 2). 
 
3.2 Solubility  
The solubility of Srx-HAp significantly and steadily increased with the increase of strontium 
content (Fig. 3). A marked change of slope in the titration curve was found for Sr1-HAp at pH ~4.2, 
similar to that seen for HAp itself at ~pH 3.9 [26], but this feature appears to move steadily to 
higher pH with increase in strontium content. No other phase was found, and no change from an 
apatitic structure either side of the slope change, and in particular no evidence was found for either 
DCPD or strontium hydrogen phosphate (SrHPO4) (Fig. 4); the Sr/(Ca+Sr) ratio of the end-point 
solid was close to that of the original titrant, but the (Ca+Sr)/P ratio was lower at the lower pH in 
each case (Table 2).   
 
3.3 Seeding of titrants in SBF 
The addition of 1 mg titrant of both Sr10-HAp and Sr-HAp into SBF solution caused an appreciable 
increase in the laser output signal over the first day, above the initial step increase, with no return 
towards the original baseline. No strontium was detected in the precipitate resulting from the 
addition Sr10-HAp (Table 3); the phase was only identified as ‘pure’ HAp (Fig. 5). Likewise, 
calcium was detected in the precipitate resulting from the addition Sr-HAp (Table 3). In addition, 
carbonate was detected in each case (Fig. 6).   
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4. Discussion 
4.1 Method 
The applicability and usefulness of solid titration has been confirmed for Srx-HAp. No procedural 
problems were encountered, and the end-point determination was as clear and unambiguous as for 
work on other calcium phosphates [34] and calcium fluoride [27]. Similarly long dissolution and 
equilibration times were required, as might be expected for a closely-related system. The absolute 
nature of the mass solubility results so obtained lends confidence to the reliability of the results.  
The reproducibility of the technique may be judged from the low scatter of the points about the 
trend line in each series. 
 
4.2 Titrants 
The preparation of the various Srx-HAps, using a method similar to that used for pure HAp [35], 
relying only the change of solution composition to the required strontium proportion, was effective. 
EDX showed that the Sr/(Ca+Sr) ratio was close to the theoretical and intended values, confirming 
the chemical homology and solid-solution nature of the system (Table 1), although the congruency 
implies that calcium is slightly favoured. The ionic radius of strontium (113 pm) is appreciably 
larger than that of calcium (99 pm), which might be thought tend to destabilize the lattice, but the 
crystal size (Fig. 2) was found to be larger with the increase of strontium content, and the 
whisker-like shape observed for Sr-HAp suggest that the increase of ionic radius favours 
preferential growth in one axis. 
 
4.3 Solubility 
The solubility of Srx-HAp increased steadily with x, indicating that the Sr does destabilize the 
structure with respect to solubility, even though Sr-HAp itself is expected to be as ordered as HAp.  
In fact, the solubility is much higher than that of pure HAp, even for Sr1-HAp (Fig. 3). The marked 
change of slope was found in all solubility isotherms, but shifted to higher pH.  Such a change of 
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slope was also found in previous work on HAp [26] and attributed to the onset of formation of 
calcium-deficient HAp (on the low pH side).  That the slope-change occurred at progressively 
higher pH implies an ion-size effect. It is noteworthy that no other phase was detected, and 
especially not DCPD, widely reported to be the most stable phase at pH < 4.2 [21].  This is 
consistent with previous results [26] showing only HAp in the low pH region. It has to be 
concluded that the true solution equilibria for strontium apatite has never been obtained by the 
conventional method through the addition of a large excess of solid to a solution; phase 
transformations in particular are suspected. 
 
For comparison, the limited data from Verbeeck et al. [30] for Sr10-HAp give a solubility isotherm 
parallel to, but substantially higher than the present results (Fig. 7).  Again, this demonstrates the 
difficulties of the large excess of solid approach, and the great supersaturation that this causes, with 
the likelihood of phase transformations. They presented no XRD or other data to support the notion 
of an equilibrated system with known solid. 
 
In passing, it may be noted that the particle size of the titrant is not of concern, that is, with respect 
to the surface energy-driven increased solubility of small particles.  All titrant is in fact expected to 
be dissolved unless, as the end-point is exceeded, that solid corresponds exactly to the stable phase.  
Solid present after the end-point has been passed is newly-nucleated (heterogeneously on titrant) 
and grown under the conditions of minute supersaturation intended for the method. 
 
Heslop et al. [16], on the basis of fitted data, postulated a “surface complex”, Ca3Sr2(PO4)3OH, that 
was very slightly less soluble that HAp, citing their calculated pK values (which require a number 
of assumptions concerning solution speciation), but with no other evidence such as XRD data 
adduced in support of the proposal. However, the present results show that the Sr-substituted 
apatites are substantially more soluble than HAp, so that any superficial ion-exchange process or 
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precipitation cannot explain such an outcome.  ‘Retarded’ HAp dissolution may thus be a kinetic 
phenomenon arising for other reasons.  A more soluble phase coating a more stable phase at 
equilibrium cannot be entertained unless both the precipitation of such a phase was driven from 
extreme supersaturation at high speed, and that such a coating is perfect, impermeable, and cannot 
itself nucleate the stable phase – for else this would occur spontaneously (Fig. 3).  
 
The effect of strontium on bone formation therefore seems not to be due to the formation of a 
surface layer retarding the dissolution of HAp, but may instead be due to the stimulation of the 
growth of osteoblasts [36], as has been widely reported. The contrary results from Cristoffersen et 
al. [14] and Dedhiya et al. [15] appear to have arisen from the method they used: using a large 
excess of solid does not permit an accurate description of the solid, and the absence of a full 
speciation model for the solution renders a solubility calculation invalid. The solubility increase 
observed now due to Sr content is consistent with a decrease of crystal stability, and with the results 
of Grynpas [12]. 
 
4.4 Behaviour in SBF 
The increase in scattering on seeding SBF indicates that either a new precipitate formed, nucleated 
on but with dissolution of that seed, or that crystal growth occurred on the seed.  That HAp was 
identified as the only phase in the precipitate resulting from seeding with Sr10-HAp, where no 
strontium was detectable, suggests the former path. Indeed, the formation of nearly Sr-free HAp is 
expected as the Sr/(Ca+Sr) ratio in the SBF (2.5 mM Ca) for 3 mg Sr10-HAp total would be about 
1.8 × 10-4.  SAED verified that the precipitate was apatitic. However, for Sr-HAp seeding, EDX 
showed that precipitate had a Ca/(Ca+Sr) ratio of about 0.10 (Table 3), for a solution molar ratio of 
about 1.8 × 10-3, indicating that a higher strontium concentration may lead to the formation of the 
substituted apatite; this may reflect ease of nucleation rather than solubility as such. 
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Such a postulation is consistent with the result in vivo of using strontium-containing materials as 
bone filler [37], when a significantly higher concentration of strontium was detected in new bone, 
but seldom in old bone.  This was true as well in OCP-like material, which is found in young bone 
but seldom in mature bone, and considered to be a precursory phase in the bone formation process 
[38], even though it is much more soluble than ‘pure’ HAp. Thus, it may be that nucleation of 
strontium-substituted apatite is easier than (biological) HAp, and this acts as a template for the 
formation of new bone, even if it is a metastable phase compared with HAp. Hence, new bone 
growth might be promoted when strontium is released from a filler material.  
  
Biological apatite is in any case a rather impure HAp. Normally described as a carbonate apatite, it 
is liable to contain many ‘foreign’ species. Here, FTIR showed an obvious adsorption peak for 
carbonate, arising from the 4.2 mM HCO3- in the SBF solution.  This presence is due to 
substitution for phosphate, as indicated by the raised (Ca+Sr)/P ratio (~2.0) (Table 3), and this is 
believed to occur readily in a physiological environment. 
 
In general, solid-titration seems to be the only viable approach for exploring the true solid – 
solution equilibria for complicated systems, and in particular for biological apatite. Its sensitivity 
and reliability suggest that it may be applied in other similarly challenging contexts. Using this 
technique, the solubility of strontium-substituted hydroxyapatite has been mapped, while seeding 
experiments support the idea of strontium-substituted apatite acting as a template for the formation 
of new bone.  
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Table 1  Calculated Sr/(Ca+Sr) ratio and (Ca+Sr)/P ratio of the prepared strontium-substituted 
hydroxyapatites, by EDX (mean ± s.d., n = 5). 
 
Substitution / % 
(theoretical original titrant) 
Sr/(Ca+Sr)  
    / % 
Congruency 
/ % 
 
(Ca+Sr)/P 
 
1 0.92 ± 0.03 92 1.66 ± 0.05 
5 4.77 ± 0.06 95 1.65 ± 0.05 
10 9.68 ± 0.20 97 1.66 ± 0.05 
40 39.90 ± 0.38 100 1.65 ± 0.05 
60 58.90 ± 0.40 98 1.65 ± 0.05 
100 100 - 1.66 ± 0.05 
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Table 2  Calculated Sr/(Ca+Sr) ratio and (Ca+Sr)/P ratio of the precipitates from solid titration at 
various pH values, by EDX (mean ± s.d., n = 5). 
 
 
 
Sr/(Ca+Sr) 
 
 
(Ca+Sr)/P 
 
Substitution 
 / % 
(theoretical 
original 
titrant) % pH % pH % pH % pH
1 0.89 ± 0.05 3.95 0.90 ± 0.04 4.67 1.57 ± 0.05 3.95 1.61 ± 0.05 4.67
5 4.67 ± 0.08 4.03  4.66 ± 0.07 4.88 1.55 ± 0.05 4.03 1.63 ± 0.05 4.88
10  9.66 ± 0.27 4.07  9.70 ± 0.31 4.91 1.58 ± 0.05 4.07 1.61 ± 0.05 4.91
40 39.51 ± 0.51 4.06 39.45 ± 0.49 4.83 1.56 ± 0.05 4.06 1.60 ± 0.05 4.83
60 58.43 ± 0.62 4.11 58.37 ± 0.59 4.96 1.54 ± 0.05 4.11 1.60 ± 0.05 4.96
100 100 4.27 100 5.01 1.55 ± 0.05 4.27 1.62 ± 0.05 5.01
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Table 3  Sr, Ca, P content and calculated Sr/(Ca+Sr) and (Ca+Sr)/P ratios of the precipitates from 
SBF solution, by EDX (mean ± s.d., n = 5). 
 
Precipitates 
Original solid in SBF 
Sr Ca P 
Sr/(Ca+Sr) 
   / % 
(Ca+Sr)/P
Sr10-HAp 0 17.88 9.31 - 1.92 ± 0.05
Sr-HAp 14.19 1.51 7.88 90.38 ± 1.77 1.99 ± 0.05 
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（figure captions） 
 
Fig. 1  XRD pattern of the solids prepared by hydrothermal method; standard XRD patterns of 
HAp (JCPDS 72-1243) and Sr-HAp (JCPDs 70-1511) for comparison. 
 
Fig. 2  Typical particle morphologies for the Sr-substituted hydroxyapatites. 
 
Fig. 3  Solubility isotherms for Sr-substituted hydroxyapatites; that for HAp included for 
comparison 26. 
 
Fig. 4   Typical precipitate morphologies at various solution pH values and corresponding 
selected-area electron diffraction (SAED) rings.  
 
Fig. 5  Precipitate morphology for addition of 1 mg Sr10-HAp, and Sr-HAp in SBF solution, and 
corresponding selected-area electron diffraction (SAED) rings.  
 
Fig. 6  Fourier-transform infrared spectra of precipitates from SBF solution; those of original 
added solids shown for comparison.  
 
Fig. 7  Comparison of solubility results for Sr10-HAp by excess-solid (open symbols) and solid 
titration (solid symbols). 
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Pan et al.
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